|
COVID-19 Vaccines
|
D000086663 |
[Vaccines or candidate vaccines containing SARS-CoV2 component antigens, genetic materials, or inactivated SARS-CoV-2 virus, and designed to prevent or treat COVID-19.
] |
|
Pituitary Hormone Release Inhibiting Hormones
|
D12.644.548.365.700 |
|
|
Afghan Campaign 2001-
|
I01.880.735.950.250.094 |
|
|
Ketanserin
|
D03.633.100.786.830.333 |
|
|
Quinazolinones
|
D03.633.100.786.830 |
|
|
rab3A GTP-Binding Protein
|
D08.811.277.040.330.300.400.400.100.500 |
|
|
rab3 GTP-Binding Proteins
|
D08.811.277.040.330.300.400.400.100 |
|
|
Diabetes Mellitus, Experimental
|
E05.598.500.374 |
|
|
Operative Blood Salvage
|
E04.936.537.687 |
|
|
Vocabulary, Controlled
|
L01.453.245.945 |
|
|
Dermatoglyphics
|
N04.452.910.099.500 |
|
|
Synthetic Lethal Mutations
|
D000072020 |
[Mutations in genes which lead to cell or organism death when occurring in combination with mutations in one or more other genes.
] |
|
Technetium Tc 99m Dimercaptosuccinic Acid
|
D02.886.489.750.725 |
|
|
Succimer
|
D02.886.489.750 |
|
|
Eosinophilic Esophagitis
|
C06.405.205.663.209 |
|
|
Analog-Digital Conversion
|
L01.224.230.260.280.080 |
|
|
Computers, Hybrid
|
L01.224.230.260.280 |
|
|
Xenophobia
|
F01.829.595.875 |
|
|
Antigenic Variation
|
G05.365.073 |
|
|
Radon
|
D01.268.613.700 |
|
